These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9116718)

  • 1. A subpopulation of WIL-2 cell calreticulin molecules is associated with RO/SS-A ribonucleoprotein particles.
    Lieu TS; Sontheimer RD
    Lupus; 1997; 6(1):40-7. PubMed ID: 9116718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calreticulin binds hYRNA and the 52-kDa polypeptide component of the Ro/SS-A ribonucleoprotein autoantigen.
    Cheng ST; Nguyen TQ; Yang YS; Capra JD; Sontheimer RD
    J Immunol; 1996 Jun; 156(11):4484-91. PubMed ID: 8666824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological cross-reactivity between a human Ro/SS-A autoantigen (calreticulin) and the lambda Ral-1 antigen of Onchocerca volvulus.
    Lux FA; McCauliffe DP; Büttner DW; Lucius R; Capra JD; Sontheimer RD; Lieu TS
    J Clin Invest; 1992 Jun; 89(6):1945-51. PubMed ID: 1602002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spreading of the immune response from 52 kDaRo and 60 kDaRo to calreticulin in experimental autoimmunity.
    Kinoshita G; Keech CL; Sontheimer RD; Purcell A; McCluskey J; Gordon TP
    Lupus; 1998; 7(1):7-11. PubMed ID: 9493142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A calreticulin-like protein co-purifies with a '60 kD' component of Ro/SSA, but is not recognized by antibodies in Sjögren's syndrome sera.
    Lu J; Willis AC; Sim RB
    Clin Exp Immunol; 1993 Dec; 94(3):429-34. PubMed ID: 8252803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of ultraviolet radiation on the cellular expression of Ro/SS-A-autoantigenic polypeptides.
    Kawashima T; Zappi EG; Lieu TS; Sontheimer RD
    Dermatology; 1994; 189 Suppl 1():6-10. PubMed ID: 8049566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of antibodies to Ro/SS-A and La/SS-B in subacute cutaneous lupus erythematosus and related conditions.
    Zappi E; Sontheimer R
    Immunol Invest; 1993 Apr; 22(3):189-203. PubMed ID: 8509157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-calreticulin segregates anti-Ro sera in systemic lupus erythematosus: anti-calreticulin is present in sera with anti-Ro alone but not in anti-Ro sera with anti-La or anti-ribonucleoprotein.
    Scofield RH; Racila DM; Gordon TP; Kurien BT; Sontheimer RD
    J Rheumatol; 2000 Jan; 27(1):128-34. PubMed ID: 10648028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of the Ro/SS-A autoimmune response.
    Sontheimer RD; Lieu TS; McCauliffe DP
    Semin Dermatol; 1991 Sep; 10(3):199-205. PubMed ID: 1931569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C1q inhibits autoantibody binding to calreticulin.
    Racila DM; Sontheimer RD
    Lupus; 1999; 8(4):300-4. PubMed ID: 10413209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of ultraviolet irradiation on expression of SSA/Ro autoantigenic polypeptides in transformed human epidermal keratinocytes.
    Kawashima T; Zappi EG; Lieu TS; Sontheimer RD
    Lupus; 1994 Dec; 3(6):493-500. PubMed ID: 7704007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the autoantigen calreticulin.
    Rokeach LA; Haselby JA; Meilof JF; Smeenk RJ; Unnasch TR; Greene BM; Hoch SO
    J Immunol; 1991 Nov; 147(9):3031-9. PubMed ID: 1919005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic lupus erythematosus is associated with increased auto-antibody titers against calreticulin and grp94, but calreticulin is not the Ro/SS-A antigen.
    Boehm J; Orth T; Van Nguyen P; Söling HD
    Eur J Clin Invest; 1994 Apr; 24(4):248-57. PubMed ID: 8050453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calreticulin binds preferentially with B cell linear epitopes of Ro60 kD autoantigen, enhancing recognition by anti-Ro60 kD autoantibodies.
    Staikou EV; Routsias JG; Makri AA; Terzoglou A; Sakarellos-Daitsiotis M; Sakarellos C; Panayotou G; Moutsopoulos HM; Tzioufas AG
    Clin Exp Immunol; 2003 Oct; 134(1):143-50. PubMed ID: 12974767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular chaperones are targets of autoimmunity in Ro(SS-A) immune mice.
    Kinoshita G; Purcell AW; Keech CL; Farris AD; McCluskey J; Gordon TP
    Clin Exp Immunol; 1999 Feb; 115(2):268-74. PubMed ID: 9933452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human Ro/SS-A autoantigen is the homologue of calreticulin and is highly homologous with onchocercal RAL-1 antigen and an aplysia "memory molecule".
    McCauliffe DP; Zappi E; Lieu TS; Michalak M; Sontheimer RD; Capra JD
    J Clin Invest; 1990 Jul; 86(1):332-5. PubMed ID: 2365822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete congenital heart block is associated with increased autoantibody titers against calreticulin.
    Orth T; Dorner T; Meyer Zum Buschenfelde KH; Mayet WJ
    Eur J Clin Invest; 1996 Mar; 26(3):205-15. PubMed ID: 8904349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of murine monoclonal antibodies against 60-kD Ro/SS-A and La/SS-B autoantigens.
    Veldhoven CH; Pruijn GJ; Meilof JF; Thijssen JP; Van der Kemp AW; Van Venrooij WJ; Smeenk RJ
    Clin Exp Immunol; 1995 Jul; 101(1):45-54. PubMed ID: 7621591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolin associates with a subset of the human Ro ribonucleoprotein complexes.
    Fouraux MA; Bouvet P; Verkaart S; van Venrooij WJ; Pruijn GJ
    J Mol Biol; 2002 Jul; 320(3):475-88. PubMed ID: 12096904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiological roles of calreticulin in autoimmune disease.
    Eggleton P; Llewellyn DH
    Scand J Immunol; 1999 May; 49(5):466-73. PubMed ID: 10320638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.